TickerFacts.

Bioharvest Sciences Inc. (BHST): Cash & Equivalents

Annual figures by period end, from SEC filings.

$23.02M
As of 2025-12-31
2023-12-31: $5.36M2024-12-31: $2.39M2025-12-31: $23.02M$23.02M
2023-12-31 Cash & Equivalents (USD) 2025-12-31
Period endedCash & EquivalentsChange YoYSource filing
2025-12-31$23.02M+863.4%2026-03-31, Balance as of period end
2024-12-31$2.39M-55.4%2026-03-31, Balance as of period end
2023-12-31$5.36Mn/a2025-03-31, Balance as of period end

Cash & Equivalents at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCash & EquivalentsChange YoY
Bioharvest Sciences Inc. (BHST)2025-12-31$23.02M+863.4%
Verrica Pharmaceuticals Inc. (VRCA)2025-12-31$30.15M-34.9%
Earth Science Tech, Inc. (ETST)2026-03-31$796.8K-45.9%
Lftd Partners Inc. (LIFD)2025-12-31$1.77M-17.7%
Zomedica Corp. (ZOMDF)2025-12-31$9.02M+28.4%
BGM Group Ltd. (BGM)2025-09-30$9.82M0.0%
Verastem, Inc. (VSTM)2025-12-31$204.99M+130.8%
Foghorn Therapeutics Inc. (FHTX)2025-12-31$80.88M+45.8%
Biofrontera Inc. (BFRI)2025-12-31$6.39M+8.2%

Compare BHST, VRCA, ETST, LIFD side by side · Screen every company in Pharmaceutical Preparations ↗